Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2023

Equity [Abstract]

Share-Based Payment Arrangement, Expensed and Capitalized, Amount

The following table summarizes our share-based compensation expense, which consists of the RSU expense, by line item in our condensed consolidated statements of income (in millions):

	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Cost of revenue	$	193	$	213	$	352	$	373
Research and development	3,305		2,606		5,754		4,547
Marketing and sales	289		289		509		506
General and administrative	273		243		496		424
Total share-based compensation expense	$	4,060	$	3,351	$	7,111	$	5,850

Restricted Stock Units Award Activity

The following table summarizes the activities for our unvested RSUs for the six months ended June 30, 2023:

	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
	(in thousands)
Unvested at December 31, 2022	127,110	$	216.93
Granted	107,550	$	197.24
Vested	(31,987)	$	210.65
Forfeited	(19,704)	$	210.36
Unvested at June 30, 2023	182,969	$	207.16